Prolight Diagnostics AB (publ)

NGM:PRLD Stock Report

Market Cap: SEK 203.6m

Prolight Diagnostics Management

Management criteria checks 4/4

Prolight Diagnostics' CEO is Ulf Bladin, appointed in Jul 2020, has a tenure of 6.08 years. directly owns 57.93% of the company’s shares, worth SEK117.92M. The average tenure of the management team and the board of directors is 4.6 years and 4.3 years respectively.

Key information

Ulf Bladin

Chief executive officer

SEK 3.3m

Total compensation

CEO salary percentagen/a
CEO tenure6.1yrs
CEO ownership57.9%
Management average tenure4.6yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

Analysis Article Apr 22

Is Prolight Diagnostics (NGM:PRLD) In A Good Position To Invest In Growth?

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Analysis Article Dec 23

Is Prolight Diagnostics (NGM:PRLD) In A Good Position To Invest In Growth?

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Analysis Article Jul 14

Is Prolight Diagnostics (NGM:PRLD) In A Good Position To Invest In Growth?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article Nov 07

Companies Like Prolight Diagnostics (NGM:PRLD) Can Afford To Invest In Growth

We can readily understand why investors are attracted to unprofitable companies. For example, although...
Analysis Article Jul 06

We Think Prolight Diagnostics (NGM:PRLD) Can Easily Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Analysis Article Mar 09

Companies Like Prolight Diagnostics (NGM:PRLD) Are In A Position To Invest In Growth

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Analysis Article Nov 24

Prolight Diagnostics (NGM:PRLD) Is In A Good Position To Deliver On Growth Plans

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

CEO

Ulf Bladin (62 yo)

6.1yrs
Tenure
SEK 3,349,000
Compensation

Mr. Ulf Bladin served as Director of Lumito AB (publ) since 2019 until 2025. Mr. Bladin serves as Director of Prolight Diagnostics AB (publ) since 2021. He served as Director at Cardeon AB (publ).Mr. Blad...


Leadership Team

NamePositionTenureCompensationOwnership
Ulf Bladin
CEO & Director6.1yrsSEK 3.35m57.93%
SEK 117.9m
Henrik Ljung
Chief Financial Officer4.6yrsno datano data
Karl Bullen
Chief Operating Officerno datano datano data
Steven Ross
CTO & Directorno datano data2.62%
SEK 5.3m
Aileen McGettrick
CSO & Directorno datano data2.62%
SEK 5.3m
Paul Monaghan
Head of Engineeringno datano data2.62%
SEK 5.3m
Andrew Goodenough
Head of Regulatoryno datano datano data
Julie Richards
Head of Assay Developmentno datano data2.62%
SEK 5.3m
Sarah Campbell
Head of Product Developmentno datano datano data
Mireille Hanjaree
Head of Qualityless than a yearno datano data
4.6yrs
Average Tenure

Experienced Management: PRLD's management team is considered experienced (4.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ulf Bladin
CEO & Director5.6yrsSEK 3.35m57.93%
SEK 117.9m
Steven Ross
CTO & Director4.3yrsno data2.62%
SEK 5.3m
Aileen McGettrick
CSO & Director4.3yrsno data2.62%
SEK 5.3m
Tobias Volker
Director4.3yrsno data0.15%
SEK 306.0k
Fredrik Alpsten
Chairman of the board1.1yrsno datano data
Kiarash Farr
Directorno datano datano data
Matt Reed
Member of Clinical Advisory Board1.2yrsno datano data
4.3yrs
Average Tenure
60yo
Average Age

Experienced Board: PRLD's board of directors are considered experienced (4.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/18 01:40
End of Day Share Price 2026/08/18 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Prolight Diagnostics AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.